Free shipping on all orders over $ 500

 About 1 result found for searched term "918127-53-4" (0.125 seconds)

Cat.No.  Name Target
M25291 Tigatuzumab Apoptosis
CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.